TAK·874060205·US·adr·Healthcare - Drug Manufacturers - Specialty & Generic
SPONSORED ADS
TAK (TAKEDA PHARMACEUTICAL CO LTD) is held by 122 institutional investors as of Q4 2025. Largest holders: ENVESTNET ASSET MANAGEMENT INC ($26.1M), QRG CAPITAL MANAGEMENT, INC. ($6.8M), ASSETMARK, INC ($4.2M). Net institutional sentiment: Mixed.
See how TAK's score breaks down across 4 SEC sources
Showing 30 of 122 results.92 more with Pro.PROUpgrade to see all → |
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer